Category: Media Release

Microbio Expands into Greece with ELTA 90 MGR as Exclusive Distributor 

At Microbio, we’re proud to announce our latest step in global expansion – the signing of an exclusive distribution agreement with ELTA 90 MGR, a prominent distributor of advanced medical and laboratory diagnostics, to bring Microbio’s cutting-edge products to the Greek healthcare market. This strategic partnership is a key milestone in Microbio’s global expansion plan… Continue reading Microbio Expands into Greece with ELTA 90 MGR as Exclusive Distributor 

Microbio Expands into Italy: LionDx Appointed as Exclusive Distributor

At Microbio, we’re excited to announce our latest milestone – the appointment of LionDx as our exclusive distributor in Italy. This partnership marks a significant step forward in expanding access to our innovative pathogen diagnostic solutions throughout Europe. Enhancing healthcare outcomes with InfectID-BSI™ Our flagship product, InfectID-BSI™, is at the core of this partnership. InfectID-BSI™… Continue reading Microbio Expands into Italy: LionDx Appointed as Exclusive Distributor

Microbio featured on Smart Company

Microbio has been featured by Smart Company in an article highlighting the commercialisation of InfectID-BSI and how it has benefitted from our participation in the Brisbane Economic Development Agency’s MedTech Accelerator program. Microbio develops pathogen test to identify and treat sepsis (smartcompany.com.au)

Microbio closes latest investment round after surpassing $3.5m target

Queensland biotechnology scale-up Microbio has closed its latest investment round after surpassing its $3.5 million target. This investment will facilitate Microbio expanding regulatory approval into international markets, having already received clearance for distribution and use in Europe and the UK, with approval in India and South America expected by the end of 2022, and TGA… Continue reading Microbio closes latest investment round after surpassing $3.5m target